Galectin-9 Signaling Drives Breast Cancer Invasion through Extracellular Matrix

Authors:

Abstract
Aberrations in glycan and lectin expression and function represent one of the earliest hallmarks of cancer. Among galectins, a conserved family of β-galactoside-binding lectins, the role of Galectin-9 in immune-tumor interactions is well-established, although its effect on cancer cell behavior remains unclear. In this study, we assayed for, and observed, an association between Galectin-9 expression and invasiveness of breast cancer cells in vitro and in vivo. Genetic perturbation and pharmacological inhibition using novel cognate inhibitors confirmed a positive correlation between Galectin-9 levels and the adhesion of invasive cancer cells to─and their invasion through─constituted organomimetic extracellular matrix microenvironments. Signaling experiments and unbiased quantitative proteomics revealed Galectin-9 induction of Focal Adhesion Kinase activity and S100A4 expression, respectively. FAK inhibition decreased S100A4 mRNA levels. Our results provide crucial insights into how elevated Galectin-9 expression potentiates the invasiveness of breast cancer cells during early steps of invasion.
Funding Information
  • Vetenskapsrådet (621-2020-03317)
  • Wellcome Trust DBT India Alliance (IA/I/17/2/ 503312)
  • Anusandhan National Research Foundation (ECR/2015/000280)
  • Indian Institute of Science (BT/PR27952/INF/22/212/2018)
  • Department of Biotechnology , Ministry of Science and Technology (BT/ 909 PR26526/GET/119/92/201)
  • Galecto
  • Institute of Eminence (IE/CARE-19-0319)

This publication has 46 references indexed in Scilit: